Vicarious Surgical (RBOT) Return on Capital Employed (2021 - 2025)
Vicarious Surgical (RBOT) reported Return on Capital Employed of 174.52% for Q3 2025, down 8889.0% year-over-year from 1.99% in Q3 2024, and down 20.68% quarter-over-quarter from 144.61% in Q2 2025.
Vicarious Surgical (RBOT) Return on Capital Employed (2021 - 2025) Analysis & Trends
Vicarious Surgical (RBOT) has 5 years of Return on Capital Employed data on file, last reported at 174.52% in Q3 2025.
- Return on Capital Employed for Q3 2025 came in at 174.52%, down 8889.0% year-over-year; the trailing twelve-month figure through Sep 2025 was 174.52% (down 8889.0% YoY), and the FY2024 annual result was 77.28%, down 1159.0% from the prior year.
- Return on Capital Employed slipped to 174.52% in Q3 2025 per RBOT's latest filing, from 144.61% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 5.52% in Q2 2021 and troughed at 174.52% in Q3 2025.
- A 5-year average of 68.0% and a median of 67.97% in 2023 frame the typical range for Return on Capital Employed.
- The sharpest annual moves came in 2024 and 2025: Return on Capital Employed surged 542 bps in 2024, then slumped 8889 bps in 2025.
- A 5-year view of Return on Capital Employed shows it stood at 21.09% in 2021, then sank by 177 bps to 58.41% in 2022, then slipped by 16 bps to 67.97% in 2023, then tumbled by 47 bps to 100.08% in 2024, then plunged by 74 bps to 174.52% in 2025.
- Business Quant data shows RBOT's Return on Capital Employed at 174.52% in Q3 2025, 144.61% in Q2 2025, and 123.65% in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 7.36% |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 11.13% |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 9.30% |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 10.45% |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 24.24% |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 11.57% |
| 10 | Vicarious Surgical | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -174.52% |
| Jun 30, 2025 | -144.61% |
| Mar 31, 2025 | -123.65% |
| Dec 31, 2024 | -100.08% |
| Sep 30, 2024 | -85.63% |
| Jun 30, 2024 | -76.75% |
| Mar 31, 2024 | -69.27% |
| Dec 31, 2023 | -67.97% |
| Sep 30, 2023 | -77.60% |
| Jun 30, 2023 | -82.17% |
| Mar 31, 2023 | -67.90% |
| Dec 31, 2022 | -58.41% |
| Sep 30, 2022 | -53.05% |
| Jun 30, 2022 | -38.57% |
| Mar 31, 2022 | -29.34% |
| Dec 31, 2021 | -21.09% |
| Sep 30, 2021 | -9.08% |
| Jun 30, 2021 | -5.52% |
| Mar 31, 2021 | -6.86% |